Javascript must be enabled to continue!
Lymphotoxin β receptor signalling executes Helicobacter pylori -driven gastric inflammation in a T4SS-dependent manner
View through CrossRef
Objective
Lymphotoxin β receptor (LTβR) signalling has been implicated in inflammation-associated tumour development in different tissues. We have analysed the role of LTβR and alternative NF-κB signalling in
Helicobacter pylori-
mediated gastric inflammation and pathology.
Design
We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of
H. pylori
-infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses. Molecular mechanisms involved in LTβR activation by
H. pylori
were assessed in vitro using human gastric cancer cell lines and distinct
H. pylori
isolates. The effects of blocking or agonistically activating LTβR on gastric pathology during challenge with a human pathogenic
H. pylori
strain were studied in a mouse model.
Results
Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of
H. pylori
-infected patients.
H. pylori
induced LTβR–ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection. Blocking LTβR signalling in vivo suppressed
H. pylori-
driven gastritis, whereas LTβR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology.
Conclusions
LTβR-triggered activation of alternative NF-κB signalling in gastric epithelial cells executes
H. pylori
-induced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by
H. pylori
, while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.
Title: Lymphotoxin β receptor signalling executes
Helicobacter pylori
-driven gastric inflammation in a T4SS-dependent manner
Description:
Objective
Lymphotoxin β receptor (LTβR) signalling has been implicated in inflammation-associated tumour development in different tissues.
We have analysed the role of LTβR and alternative NF-κB signalling in
Helicobacter pylori-
mediated gastric inflammation and pathology.
Design
We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of
H.
pylori
-infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses.
Molecular mechanisms involved in LTβR activation by
H.
pylori
were assessed in vitro using human gastric cancer cell lines and distinct
H.
pylori
isolates.
The effects of blocking or agonistically activating LTβR on gastric pathology during challenge with a human pathogenic
H.
pylori
strain were studied in a mouse model.
Results
Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of
H.
pylori
-infected patients.
H.
pylori
induced LTβR–ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection.
Blocking LTβR signalling in vivo suppressed
H.
pylori-
driven gastritis, whereas LTβR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology.
Conclusions
LTβR-triggered activation of alternative NF-κB signalling in gastric epithelial cells executes
H.
pylori
-induced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by
H.
pylori
, while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.
Related Results
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer
Introduction: According to GLOBOCAN estimates for 2018, gastric cancer was the fifth most common cancer and the third most common cause of death from malignant diseases in the worl...
THE CLINICAL CHARACTERISTICS, ENDOSCOPIC FINDINGS AND THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN INTREATMENT OF PATIENTS WITH HELICOBACTER PYLORIGASTRODUODENAL INFLAMMATORY AND ULCER AT CAN THO HOSPITAL OF UNIVERSITY OF MEDICINE AND PHARMACY
THE CLINICAL CHARACTERISTICS, ENDOSCOPIC FINDINGS AND THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN INTREATMENT OF PATIENTS WITH HELICOBACTER PYLORIGASTRODUODENAL INFLAMMATORY AND ULCER AT CAN THO HOSPITAL OF UNIVERSITY OF MEDICINE AND PHARMACY
Background: Helicobacter pylori causes inflammation of the gastric mucosa and is associated with many upper gastrointestinal diseases, including chronic gastritis, peptic ulcer dis...
Helicobacter pylori-Positive Gastric Biopsies—Association with Clinical Predictors
Helicobacter pylori-Positive Gastric Biopsies—Association with Clinical Predictors
Introduction: Although Helicobacter pylori’s role in gastric oncogenesis is well-known, only a fraction of infected patients develop cancer. Hence, more factors are supposed to be ...
Clinicopathological Characteristics and Endoscopic Features of Early Gastric Cancers Diagnosed After Helicobacter pylori Eradication
Clinicopathological Characteristics and Endoscopic Features of Early Gastric Cancers Diagnosed After Helicobacter pylori Eradication
Abstract
Background. Helicobacter pylori (H. pylori) infection is an important risk factor for developing gastric cancer. However, even after H. pylori eradication, early g...
Helicobacter pylori Isolate from Endoscopy Examined Patients in Bahir Dar, North West Ethiopia Helicobacter pylori Isolate from Endoscopy Examined Patients in Bahir Dar, North West Ethiopia
Helicobacter pylori Isolate from Endoscopy Examined Patients in Bahir Dar, North West Ethiopia Helicobacter pylori Isolate from Endoscopy Examined Patients in Bahir Dar, North West Ethiopia
Background: The Helicobacter pylori infection is highly prevalent throughout the world and causes gastric-associated diseases. Its microbial niche is the stomach, where it causes d...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract
Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...

